cardiac pain

cardiac pain

References in periodicals archive ?
A lawyer for Dr Asim Hussain informed the court that his client had been taken to the hospital after he complained of cardiac pain.
Counsel of the Pervez Musharraf' Khalid Ranjha told the court that his client was on his way to court when he had to be shifted to Armed Forces of Institute of Cardiology [AFIC] due to cardiac pain.
We followed all patients for 72 h to determine if an ACS hospitalization occurred (combined outcome of AMI or a hospitalization for unstable angina or refractory ischemic cardiac pain, defined as recurrent ischemic symptoms lasting 15 min or more, along with documented electrocardiographic changes indicative of ischemia or leading to a referral for an additional intervention such as thrombolytic therapy or cardiac catheterization or revascularization).
The patient is doing well without cardiac pain, leads a normal life and does not suffer any discomfort.
The court heard evidence from Professor Celia Oakley, of Imperial College London, who said Mrs Hymers had shown obvious signs of cardiac pain and that "she would not have been allowed to die" if she had been admitted to hospital.
More specific discussion of the patient's symptoms and the features (eg, sharpness, localization, relation to deep breathing, predominance at rest) that clearly distinguish this condition from cardiac pain is important.
The cardiology team at the Beaumont Heart Center is planning to conduct several studies to look at the cause and extent of narrowing of the coronary arteries, the blood vessels that supply the heart, plus the presence of other causes of non-cardiac pain, in patients admitted to the emergency department for chest pain classified as "low risk" cardiac pain.
The former federal minister of petroleum and incumbent chairman Sindh Public Service Commission was admitted at the National Institute of Cardio Vascular Diseases (NICVD) in Karachi after he complained cardiac pain last Tuesday.
In the morning, he complained of cardiac pain and suffocation again and was taken to Combine Military Hospital (CMH) for treatment.
We followed up patients (n = 186) directly at 72 h after presentation to determine if they experienced any of the study outcomes: MI, heart failure, serious arrhythmia, refractory ischemic cardiac pain, or death (10).
The FDA received CV Therapeutics' NDA submission on December 30, 2002, in which the Company seeks approval to market Ranexa for the treatment of chronic angina, a serious condition marked by repeated and sometimes unpredictable attacks of cardiac pain.